iBio (IBIO) Announces Deal With Safi Biosolutions To Develop Cytokines And Growth Factors
iBio, Inc. (AMEX: IBIO) soared 5.85% after the company has signed a Master Service Agreement with Safi Biosolutions, Inc. to develop cytokines and growth factors using the FastPharming system. As per the agreement, Safi will assess the FastPharming system of iBio for the checking of key proteins to be used in the bioprocessing of Safi […]